Prognostic significance of the number of tumor (+) N2 nodes in N2 stage IIIA non-small cell lung cancer after curative resection.

被引：0
|
作者：
Yoo, C.
Yoon, S.
Lee, D.
Suh, C.
Lee, J.
Park, S.
Kim, D.
Kim, Y.
Kim, W.
Kim, S.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac Surg, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul, South Korea
[4] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7023
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer
    Kawasaki, Keishi
    Sato, Yasunori
    Suzuki, Yoshio
    Saito, Haruhisa
    Nomura, Yukihiro
    Yoshida, Yukihiro
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 21 (03) : 217 - 222
  • [42] Prognostic Factors in Patients with Pathological and N2 Non-Small Cell Lung Cancer
    Saito, Makoto
    Kato, Harubumi
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 14 (01) : 1 - 2
  • [43] Clinical significance of 18F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer:: A retrospective study
    Na, Im Il
    Cheon, Gi Jeong
    Choe, Du Hwan
    Byun, Byung Hyun
    Kang, Hye Jin
    Koh, Jae Soo
    Park, Jong Ho
    Baek, Hee Jong
    Ryoo, Baek-Yeol
    Lee, Jae Cheol
    Yang, Sung Hyun
    LUNG CANCER, 2008, 60 (01) : 69 - 74
  • [44] Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea, F
    Marulli, G
    Callegaro, D
    Zuin, A
    Gobbi, T
    Loy, M
    Sartori, F
    LUNG CANCER, 2004, 45 (02) : 215 - 220
  • [45] Clinical Impact of the Tumor Immune Microenvironment and Immunoscore in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer
    Feng, W.
    Fu, X.
    Cai, X.
    Zhang, Q.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1872 - S1872
  • [46] Impact of N2 Extent and Nodal Response on Survival after Trimodal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer
    Kim, Hong Kwan
    Cho, Jong Ho
    Choi, Yong Soo
    Zo, Jae Ill
    Shim, Young Mog
    Park, Keunchil
    Ahn, Myung-Ju
    Ahn, Jin Seok
    Ahn, Yong Chan
    Pyo, Hong Ryull
    Han, Joungho
    Kim, Hojoong
    Kim, Jhingook
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S874 - S874
  • [47] Brain metastases in patients with stage N2 non-small cell lung cancer
    Lowrie, C.
    McCully, E.
    Ansel, S.
    McLoone, P.
    Mohammed, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S69 - S69
  • [48] Risk Factors of Brain Metastases in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer
    Zhang, Qin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S622 - S622
  • [49] A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer
    Takamori, S
    Rikimaru, T
    Hayashi, A
    Tayama, K
    Mitsuoka, M
    Fujimoto, K
    Horiuchi, M
    Hayabuchi, N
    Oizumi, K
    Shirouzu, K
    LUNG CANCER, 2000, 29 (01) : 49 - 56
  • [50] Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspectiveaEuro
    Rocco, Gaetano
    Nason, Katie
    Brunelli, Alex
    Varela, Gonzalo
    Waddell, Thomas
    Jones, David R.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (04) : 1025 - 1027
12345